Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Docetaxel polymeric micelle - Samyang Biopharmaceuticals Corporation

Next Previous
X
Search
Drug Profile

Docetaxel polymeric micelle - Samyang Biopharmaceuticals Corporation

Alternative Names: B 5704; Docetaxel-PM; NanoxelM; SYP-0704A

Latest Information Update: 28 May 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Samyang Biopharmaceuticals Corporation
  • Class Antineoplastics; Small molecules; Taxanes
  • Mechanism of Action Mitosis inhibitors; Tubulin modulators; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Breast cancer; Gastric cancer; Non-small cell lung cancer; Ovarian cancer; Prostate cancer; Squamous cell cancer
  • Discontinued Bladder cancer

Most Recent Events

  • 09 May 2024 Samyang Biopharmaceuticals Corporation terminates phase III trial in Breast cancer (Neoadjuvant therapy) in South Korea (IV), due to difficulties in recruiting participants and conducting the study (NCT05207514)
  • 30 Dec 2022 Discontinued - Phase-III for Bladder cancer (Second-line therapy or greater) in South Korea (Intravesicular)
  • 22 Mar 2022 Phase-III clinical trials in Breast cancer (Neoadjuvant therapy) in South Korea (IV) (NCT05207514)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top